pillbase.ru

ZYNYZ

Active substance: retifanlimab

INJECTION · RETIFANLIMAB 25 mg/mL

United StatesActive

Marketing holder: Incyte Corporation

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Zynyz
    retifanlimab
    EMEA/H/C/006194
    Incyte Biosciences Distribution B.V.
  • Zynyz
    retifanlimab
    EMEA/H/C/005632
    Incyte Biosciences Distribution B.V.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12098-be7f-7f9e-b676-8457499ea983;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
50881-006
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 50881-006 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 50881-006 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 50881-006 · Verified 2026-10-09 · open in source